Taztia XT (Diltiazem Hydrochloride) - Summary

TAZTIA XT SUMMARY

Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker).

Hypertension

Diltiazem Hydrochloride Extended-Release Capsules USP (Once-a-Day Dosage) are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications.

Chronic Stable Angina

Diltiazem Hydrochloride Extended-Release Capsules USP (Once-a-Day Dosage) are indicated for chronic stable angina.

See all Taztia XT indications & dosage >>

TAZTIA XT NEWS HIGHLIGHTS

Published Studies Related to Taztia XT (Diltiazem)

Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study. [2008.07]

The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects. [2008.05]

Conversion of atrial fibrillation to sinus rhythm during treatment with intravenous esmolol or diltiazem: a prospective, randomized comparison. [2007.09]

Effect of diltiazem and metoprolol on left atrial appendix functions in patients with nonvalvular chronic atrial fibrillation. [2007.03]

A comparison of the effects of diltiazem and glyceryl trinitrate ointment in the treatment of chronic anal fissure: a randomized clinical trial. [2007]

more >>

Clinical Trials Related to Taztia XT (Diltiazem)

Bioequivalence Study Of Verapamil [Recruiting]

Effect Study of Intracoronary Infusion of Diltiazem, Verapamil and Nitroglycerin on No-Reflow During Percutaneous Coronary Intervention (PCI) [Recruiting]

An Interaction Study of Ketoconazole/Verapamil Versus AZD1305 [Recruiting]

Adalat ® XL® vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients [Not yet recruiting]

Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem [Recruiting]

more >>